A5004382958- Advanced Radiotherapy Techniques
- Brain Metastases and Treatment
- Glioma Diagnosis and Treatment
- Breast Cancer Treatment Studies
- Advances in Oncology and Radiotherapy
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Medical Imaging Techniques and Applications
- Radiopharmaceutical Chemistry and Applications
- Prostate Cancer Treatment and Research
- Meningioma and schwannoma management
- Radiomics and Machine Learning in Medical Imaging
- Cardiac electrophysiology and arrhythmias
- Lung Cancer Diagnosis and Treatment
- Radiation Dose and Imaging
- COVID-19 and healthcare impacts
- Radiation Therapy and Dosimetry
- Prostate Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Management of metastatic bone disease
- Cardiac pacing and defibrillation studies
- Cancer Genomics and Diagnostics
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer survivorship and care
- Breast Lesions and Carcinomas
Ospedale Generale Regionale Francesco Miulli
2018-2024
Weill Cornell Medicine
2023-2024
Cornell University
2023-2024
Ospedale Sacro Cuore Don Calabria
2017-2019
Istituti di Ricovero e Cura a Carattere Scientifico
2018-2019
University of Padua
2012-2018
In the randomized phase II REGOMA trial, regorafenib showed promising activity in patients with recurrent glioblastoma. We conducted a large, multicenter, prospective, observational study to confirm data real-world setting.
Background/Objectives: Hypofractionated radiation therapy (Hypo-RT) schedules may offer radiobiological, patient convenience, and healthcare resource advantages over standard fractionated (S-RT) for glioblastoma (GBM). Additionally, simulated integrated boost (SIB) Hypo-RT is proven to be an effective safe treatment. We report on our experience regarding progression-free survival (PFS), overall (OS), RT-related toxicities in GBM patients treated with S-RT. Methods: Patients IDH-wildtype...
Breast cancer is the most common tumor in women and represents leading cause of death. Radiation therapy plays a key-role treatment all breast stages. Therefore, adoption evidence-based treatments warranted, to ensure equity access standardization care clinical practice.This national document on highest available data was developed endorsed by Italian Association Clinical Oncology (AIRO) Cancer Group.We analyzed literature regarding radiation therapy, using SIGN (Scottish Intercollegiate...
Abstract Background Anaplastic large cell lymphoma (ALCL) represents approximately 15% of all pediatric non‐Hodgkin lymphomas (NHL). It has distinct clinical features, including frequent involvement extranodal sites and rare localization to the central nervous system (CNS). Despite varying treatment approaches outcome patients with ALCL not significantly improved during last two decades. Procedure From October 1997 beginning 2000, newly diagnosed were enrolled into AIEOP LNH‐97 protocol for...
Abstract Background Intraoperative radiotherapy with electrons (IOERT) boost could be not inferior to external beam (EBRT) in terms of local control and tissue tolerance. The aim the study is present long-term follow-up results on control, esthetic evaluation, toxicity a prospective early-stage breast cancer patients treated breast-conserving surgery an IOERT 10 Gy (experimental group) versus 5 × 2 EBRT (standard arm). Both arms received whole-breast irradiation (WBI) 50 (2 single dose)....
Glioblastoma (GBM) is a very poor-prognosis brain tumor. To date, maximal excision followed by radiochemotherapy, in 30 fractions, the standard approach. Limited data are present literature about hypofractionated radiotherapy (hypo-RT) GBM poor prognosis patients. Thus, this retrospective study was conducted to evaluate efficacy and toxicity of hypo-RT with simultaneous integrated boost (SIB) association temozolomide (TMZ) patient setting.Poor-prognosis patients underwent surgery (complete,...
Abstract Aims Stereotactic arrhythmia radioablation (STAR) is a novel therapeutic approach for cardiac arrhythmias. The aim of this trial to investigate the feasibility STAR treatment paroxysmal atrial fibrillation (AF) in elderly patients. Methods and results Inclusion criteria were age >70 years, symptomatic AF, antiarrhythmic drugs failure, or intolerance. All patients underwent 4D computed tomography simulation. clinical target volume was identified area around pulmonary veins...